Back
Vertex Pharmaceuticals Stock Price Chart
Sponsored
VRTX
Sponsored
Forget 99.987% of Stocks (Use This ONE Instead)
See how to make massive profits by abandoning 8,251 of the 8,252 publicly traded stocks!
Buy
63
VRTX
Vertex Pharmaceuticals
Last Price:
351.07
Seasonality Move:
0.68%
7 Day Trial
ALL ACCESS PASS
$
7
This A.I. system is like having 100k financial analysts on hand
Get here to get the full story- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing slight selling pressure.
Vertex Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 350.06 | Buy |
20-day SMA: | 348.25 | Buy |
50-day SMA: | 349.78 | Buy |
200-day SMA: | 323.58 | Buy |
8-day EMA: | 349.91 | Buy |
20-day EMA: | 349.37 | Buy |
50-day EMA: | 347.47 | Buy |
200-day EMA: | 325.81 | Buy |
Vertex Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.39 | Buy |
Relative Strength Index (14 RSI): | 52.87 | Buy |
Chaikin Money Flow: | -201053 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (344.84 - 352.12) | Buy |
Bollinger Bands (100): | (334.41 - 352.87) | Buy |
Vertex Pharmaceuticals Technical Analysis
Aug 21 | Aug 22 | Aug 23 | Aug 24 | Aug 25 | Aug 28 | Aug 29 | Aug 30 | Aug 31 | Sep 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Vertex Pharmaceuticals Stock
Is Vertex Pharmaceuticals Stock a Buy?
- Vertex Pharmaceuticals share price is 351.10 while VRTX 8-day simple moving average is 350.06, which is a Buy signal.
- The stock price of VRTX is 351.10 while Vertex Pharmaceuticals 20-day SMA is 348.25, which makes it a Buy.
- Vertex Pharmaceuticals 50-day simple moving average is 349.78 while VRTX share price is 351.10, making it a Buy technically.
- VRTX stock price is 351.10 and Vertex Pharmaceuticals 200-day simple moving average is 323.58, creating a Buy signal.
VRTX Technical Analysis vs Fundamental Analysis
Buy
63
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy or a Sell?
-
Vertex Pharmaceuticals stock is rated a Buy
The current Vertex Pharmaceuticals [VRTX] share price is $351.10. The Score for VRTX is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
Vertex Pharmaceuticals Stock Info
Market Cap:
90.62B
Price in USD:
351.10
Share Volume:
714.85K
Vertex Pharmaceuticals 52-Week Range
52-Week High:
367.00
52-Week Low:
276.57
Buy
63
Vertex Pharmaceuticals (VRTX)
is a Buy
Vertex Pharmaceuticals Share Price Forecast
-
What is the Vertex Pharmaceuticals stock price today?
The Vertex Pharmaceuticals stock price is 351.10 USD today. -
Will VRTX stock go up or go down?
Vertex Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Vertex Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Vertex Pharmaceuticals is not overvalued.
Is Vertex Pharmaceuticals Stock a Buy?
- Vertex Pharmaceuticals share price is 351.10 while VRTX 8-day exponential moving average is 349.91, which is a Buy signal.
- The stock price of VRTX is 351.10 while Vertex Pharmaceuticals 20-day EMA is 349.37, which makes it a Buy.
- Vertex Pharmaceuticals 50-day exponential moving average is 347.47 while VRTX share price is 351.10, making it a Buy technically.
- VRTX stock price is 351.10 and Vertex Pharmaceuticals 200-day simple moving average is 325.81, creating a Buy signal.
Fundamental Analysis of Vertex Pharmaceuticals
Is Vertex Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.33 per share, an increase next quarter of $0.14 per share, an increase this year of $0.04 per share, and an increase next year of $1.46 per share.
Technical Analysis of Vertex Pharmaceuticals
Should I short Vertex Pharmaceuticals stock?
- VRTX Moving Average Covergence Divergence (MACD) indicator is 0.39, suggesting Vertex Pharmaceuticals is a Buy
- Vertex Pharmaceuticals Relative Strength Index (RSI) is 52.87, which suggest Vertex Pharmaceuticals is overbought
- The Bollinger Bands (25) for Vertex Pharmaceuticals is (344.84 - 352.12), which suggest Vertex Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Vertex Pharmaceuticals is (334.41 - 352.87), which suggest Vertex Pharmaceuticals is a Buy
* Vertex Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.